Clinical Trial Update: Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine [Phase 4]

View source ↗

Summary

Phase 4 trial suggests ivabradine may improve outcomes in heart failure with preserved ejection fraction patients on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Heart Failure | Phase 4 | Status: COMPLETED